Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.

by Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G., Børresen-Dale, A. l.
Published 1998

TP53 gene mutations and protein accumulation in primary vaginal carcinomas.

by Skomedal, H., Kristensen, G., Helland, A., Nesland, J. M., Kooi, S., Børresen, A. L., Holm, R.
Published 1995

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium

by Pradhan, M., Abeler, V. M., Danielsen, H. E., Sandstad, B., Tropé, C. G., Kristensen, G. B., Risberg, B. Å.
Published 2012

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

by Kaye, S, Aamdal, S, Jones, R, Freyer, G, Pujade-Lauraine, E, de Vries, E G E, Barriuso, J, Sandhu, S, Tan, D S-W, Hartog, V, Kuenen, B, Ruijter, R, Kristensen, G B, Nyakas, M, Barrett, S, Burke, W, Pietersma, D, Stuart, M, Emeribe, U, Boven, E
Published 2012